The ATX–LPA signaling axis is upregulated in metabolic conditions such as obesity and insulin resistance, and clinical studies have demonstrated elevated serum ATX levels in patients with chronic liver disease, correlated with the severity of steatosis, fibrosis, and systemic inflammation [11]. This evidence concerns the gene ENPP2 and Insulin resistance.